Rapid infusion of rituximab is well tolerated in children

0

All patients tolerated the rapid infusion of rituximab and no patient had an infusion-related reaction. We conclude that rapid infusions of rituximab are well tolerated and safe in our pilot group of patients” Bernhardt et al (2017).

Abstract:

Traditional administration of rituximab requires careful titration and may involve many hours to minimize the risk of reactions. The objective of this study was to evaluate the safety of rapid infusions of rituximab in a pilot group of children with hematologic, oncologic, and rheumatologic disorders, and to determine the incidence of rate-related infusion reactions. Twenty patients enrolled in the study. All patients tolerated the rapid infusion of rituximab and no patient had an infusion-related reaction. We conclude that rapid infusions of rituximab are well tolerated and safe in our pilot group of patients.

Reference:

Bernhardt, M.B., De Guzman, M.M., Grimes, A., Kirk, S., Nelson, S., Bergsbaken, J., Minard, C.G. and Despotovic, J.M. (2017) Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders. Paediatric Blood & Cancer. August 9th. [epub ahead of print].

DOI: 10.1002/pbc.26759

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.